AngioDynamics Inc (ANGO)
6.95
+0.21
(+3.12%)
USD |
NASDAQ |
Nov 21, 16:00
6.95
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Free Cash Flow Data
| Date | Value |
|---|---|
| February 25, 2022 | -- |
| February 24, 2022 | -- |
| February 23, 2022 | -- |
| February 22, 2022 | -- |
| February 18, 2022 | -- |
| February 17, 2022 | -- |
| February 16, 2022 | -- |
| February 15, 2022 | -- |
| February 14, 2022 | -- |
| February 11, 2022 | -- |
| February 10, 2022 | -- |
| February 09, 2022 | -- |
| February 08, 2022 | -- |
| February 07, 2022 | -- |
| February 04, 2022 | -- |
| February 03, 2022 | -- |
| February 02, 2022 | -- |
| February 01, 2022 | -- |
| January 31, 2022 | -- |
| January 28, 2022 | -- |
| January 27, 2022 | -- |
| January 26, 2022 | -- |
| January 25, 2022 | -- |
| January 24, 2022 | -- |
| January 21, 2022 | -- |
| Date | Value |
|---|---|
| January 20, 2022 | -- |
| January 19, 2022 | -- |
| January 18, 2022 | -- |
| January 14, 2022 | -- |
| January 13, 2022 | -- |
| January 12, 2022 | -- |
| January 11, 2022 | -- |
| January 10, 2022 | -- |
| January 07, 2022 | -- |
| January 06, 2022 | -- |
| January 05, 2022 | -- |
| January 04, 2022 | -- |
| January 03, 2022 | -- |
| December 31, 2021 | -- |
| December 30, 2021 | -- |
| December 29, 2021 | -- |
| December 28, 2021 | -- |
| December 27, 2021 | -- |
| December 23, 2021 | -- |
| December 22, 2021 | -- |
| December 21, 2021 | -- |
| December 20, 2021 | -- |
| December 17, 2021 | -- |
| December 16, 2021 | -- |
| December 15, 2021 | -- |
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.